Olympus Inks Distribution Deal With MacroLux Medical

Olympus Corp. announced an exclusive global distribution agreement with MacroLux Medical Technology Co. Ltd. for single-use urology product dissemination.

The agreement includes multiple single-use cystoscopes, ureteroscopes and suction access sheaths— devices used to access and visualize the bladder and urinary tract to diagnose and treat urinary diseases and disorders such as kidney stones. 

“We are excited to embark on this new partnership, a synergy that underscores our commitment to advancing patient care,” said Gabriel McHugh, executive vice president, Surgical and Interventional Solutions, at Olympus Corp. “By integrating single-use technology into our urology portfolio, we are enhancing the landscape of urological care for our customers and their patients.”

Olympus provides a range of kidney and bladder stone management and non-muscular invasive bladder cancer (NMIBC) visualization and access solutions for detection and treatment. With the addition of the MacroLux Medical single-use endoscopes and access sheath portfolio, Olympus can offer physicians increased flexibility and confidence in visualization and surgical precision, according to the company.

“Olympus is a trusted endoscopy partner for treatment of urological disease and now is positioned to provide access to a broad range of high-quality endoscopes. This includes reusable and single-use flexible scopes, rigid and semi-rigid scopes, powerful lithotripsy solutions, and gold-standard NMIBC detection,” stated Glen Branconier, senior vice president and general manager of Urology/Gynecology at Olympus Corp. “We are excited and privileged to provide urologists and healthcare providers with the tools they need to confidently care for their patients.”

The agreement includes distribution in the United States, Canada, countries across Europe and countries in the Asia Pacific (APAC) region. Countries in Europe include the United Kingdom (England, Scotland, Wales, and Northern Ireland), Ireland, Austria, Belgium, Germany, Netherlands, Luxembourg, Norway, Denmark, Switzerland, and Sweden.

Countries/regions in the APAC region include Australia, New Zealand, Hong Kong PRC, Singapore, and South Korea.

“Olympus is a respected industry leader that we admire. Our strategic cooperation with Olympus generates powerful synergies, enabling us to combine our respective strengths and accelerate the market introduction of MacroLux’s urological disposable endoscopes and access sheath solutions, products that offer clinical value,” MacroLux Medical CEO Martin Zhang added. “These products may enhance clinical efficiency and help improve patient treatment outcomes. This collaboration also inspires us to continue with product innovation and R&D, delivering clinical solutions to customers worldwide.”

The MacroLux single-use cystoscopes offer the following features: a 140° field of view; a 235° up/145° down distal tip angulation; and a 14.4Fr outer diameter with a 2.2 mm working channel. 

The MacroLux single-use ureteroscopes offer the following features: a 7.5Fr and 8.25Fr outer diameter scope offering; a 275° distal tip angulation; AutoHold Technology thumb lever control; and a 120° field of view.  

The MacroLux single-use suction access sheaths are available in multiple sizes to meet various urological procedure needs and negative pressure connection for stone removal.

Olympus partners with healthcare professionals to provide solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the care standard in targeted disease states. For more than 100 years, Olympus has strived to produce products designed with the purpose of delivering optimal outcomes for customers.

Headquartered in Shenzhen, China, MacroLux Medical Technology Co. Ltd. was established in October 2020. A medical technology company specializing in solutions for disposable endoscopic diagnosis and treatment, the founding team hails from Chinese medical device companies and possesses more than a decade of experience in the R&D, global commercialization, and production management of endoscopes and minimally invasive surgical instruments. MacroLux Medical aspires to provide disposable endoscopic diagnostic and therapeutic solutions worldwide, enabling earlier disease detection and enhanced patient treatment.